Perrigo Advances to Record High, Closes Gap With U.S. Shares
By Shoshanna Solomon -
2012-06-17T09:02:56Z
Perrigo Co. (PRGO), the largest U.S. generic over-the-counter maker of drugs, advanced to the highest on record in Tel Aviv, closing the gap with its U.S. traded shares.
The shares gained 3 percent to 432.7 shekels, or the equivalent of $112.28, at 11:37 a.m. in Tel Aviv, the highest level since March 2005, when the shares were listed in Tel Aviv. The U.S. traded shares advanced 1.1 percent to $111.62 on June 15.
To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at ssolomon22@bloomberg.net
To contact the editor responsible for this story: Claudia Maedler at cmaedler@bloomberg.net
Sponsored Link
Rate this Page
Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.